Pfizer, BioNTech ink multibillion-dollar EU deal for up to 300M doses of COVID-19 vaccine

Pfizer and partner BioNTech snared a distribution deal with the EU for up to 300 million doses of their mRNA-based COVID-19 shot candidate, BNT162b2, with initial deliveries slated by the end of the year, the companies said Tuesday.